These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 30230447)

  • 1. [Genetic data sharing: a new type of capital].
    Stoeklé HC; Forster N; Charlier P; Bloch OC; Hervé C; Turrini M; Vogt G
    Med Sci (Paris); 2018; 34(8-9):735-739. PubMed ID: 30230447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do governance, equity characteristics, and venture capital nvolvement affect long-term wealth creation in U.S. health care and biotechnology IPOs?
    Williams DR; Duncan WJ; Ginter PM; Shewchuk RM
    J Health Care Finance; 2006; 33(1):54-71. PubMed ID: 21110493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small company mergers--good for whom?
    Maybeck V; Bains W
    Nat Biotechnol; 2006 Nov; 24(11):1343-8. PubMed ID: 17093475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Capital accumulation patterns: capital and services in the current transformations of the health system].
    de Andreazzi Mde F; Kornis GE
    Cien Saude Colet; 2008; 13(5):1409-20. PubMed ID: 18813644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Data Sharing as the New Norm: What About the People Part?
    Lambertson KF; Terry SF
    Genet Test Mol Biomarkers; 2017 Feb; 21(2):63-65. PubMed ID: 28207325
    [No Abstract]   [Full Text] [Related]  

  • 6. The next controversy in genetic testing: clinical data as trade secrets?
    Cook-Deegan R; Conley JM; Evans JP; Vorhaus D
    Eur J Hum Genet; 2013 Jun; 21(6):585-8. PubMed ID: 23150081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Just how good an investment is the biopharmaceutical sector?
    Thakor RT; Anaya N; Zhang Y; Vilanilam C; Siah KW; Wong CH; Lo AW
    Nat Biotechnol; 2017 Dec; 35(12):1149-1157. PubMed ID: 29220034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Market principles in health care and social security policy in Japan.
    Akiyama H
    World Hosp Health Serv; 2004; 40(2):16-22, 40-2. PubMed ID: 15338993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Giant study poses DNA data-sharing dilemma.
    Reardon S
    Nature; 2015 Sep; 525(7567):16-7. PubMed ID: 26333450
    [No Abstract]   [Full Text] [Related]  

  • 10. Relationship between surgeons and industry.
    Jayne DG
    Br J Surg; 2019 Jul; 106(8):965-967. PubMed ID: 31260581
    [No Abstract]   [Full Text] [Related]  

  • 11. [Session 1. Is biotechnologies a laboratory for academic capitalism].
    Orsi F
    Med Sci (Paris); 2012; 28 Spec No 2():9-10. PubMed ID: 22759888
    [No Abstract]   [Full Text] [Related]  

  • 12. Business Ethics 101 for the biotech industry.
    MacDonald C
    BioDrugs; 2004; 18(2):71-7. PubMed ID: 15046523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. China commits itself to biotech in healthcare.
    Kermani F; Zhou Y
    Drug Discov Today; 2007 Jul; 12(13-14):501-3. PubMed ID: 17631243
    [No Abstract]   [Full Text] [Related]  

  • 14. Data sharing and dissemination strategies for fostering competition in health care.
    Love DE; Paita LM; Custer WS
    Health Serv Res; 2001 Apr; 36(1 Pt 2):277-90. PubMed ID: 11327177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefits and Risks of Sharing Genomic Information.
    Balaji D; Terry SF
    Genet Test Mol Biomarkers; 2015 Dec; 19(12):648-9. PubMed ID: 26588592
    [No Abstract]   [Full Text] [Related]  

  • 16. Genomic capital: public cultures and market logics of corporate biotechnology.
    Rajan KS
    Sci Cult (Lond); 2003 Mar; 12(1):87-121. PubMed ID: 15971369
    [No Abstract]   [Full Text] [Related]  

  • 17. Building a business model in digital medicine.
    Steinberg D; Horwitz G; Zohar D
    Nat Biotechnol; 2015 Sep; 33(9):910-20. PubMed ID: 26348957
    [No Abstract]   [Full Text] [Related]  

  • 18. Sharing Patient Data Without Exploiting Patients.
    McCoy MS; Joffe S; Emanuel EJ
    JAMA; 2020 Feb; 323(6):505-506. PubMed ID: 31944215
    [No Abstract]   [Full Text] [Related]  

  • 19. Myriad stands alone.
    Sherkow JS; Scott C
    Nat Biotechnol; 2014 Jul; 32(7):620. PubMed ID: 25004225
    [No Abstract]   [Full Text] [Related]  

  • 20. The development of China's medical biotech industry needs to be driven by innovation.
    Yu Z; Dai Y
    Biotechnol J; 2006 Nov; 1(11):1253-7. PubMed ID: 17068752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.